Abstract
Subarachnoid haemorrhage (SAH) is a stroke subtype with high mortality and social cost. Up to now, there are few or no specific therapy for the condition, which makes it urgent to identify new therapeutic targets. Astrocytes and endothelial cells are components of the blood-brain barrier (BBB) that have been described as protagonists in the complex pathophysiology of SAH, therefore likely…